| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |